Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.

Ashok AH, Mizuno Y, Volkow ND, Howes OD.

JAMA Psychiatry. 2017 May 1;74(5):511-519. doi: 10.1001/jamapsychiatry.2017.0135. Review.

2.

Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.

Majuri J, Joutsa J, Johansson J, Voon V, Alakurtti K, Parkkola R, Lahti T, Alho H, Hirvonen J, Arponen E, Forsback S, Kaasinen V.

Neuropsychopharmacology. 2017 Apr;42(5):1169-1177. doi: 10.1038/npp.2016.265. Epub 2016 Nov 24.

3.

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine.

Collo G, Cavalleri L, Spano P.

Front Pharmacol. 2014 Nov 25;5:259. doi: 10.3389/fphar.2014.00259. eCollection 2014. Review.

4.

Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.

Hou H, Wang C, Jia S, Hu S, Tian M.

Neurosci Bull. 2014 Oct;30(5):765-76. doi: 10.1007/s12264-014-1469-5. Epub 2014 Sep 28. Review.

5.

Mechanisms of body weight fluctuations in Parkinson's disease.

Kistner A, Lhommée E, Krack P.

Front Neurol. 2014 Jun 2;5:84. doi: 10.3389/fneur.2014.00084. eCollection 2014. Review.

6.

Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.

Bloomfield MA, Pepper F, Egerton A, Demjaha A, Tomasi G, Mouchlianitis E, Maximen L, Veronese M, Turkheimer F, Selvaraj S, Howes OD.

Neuropsychopharmacology. 2014 Sep;39(10):2397-404. doi: 10.1038/npp.2014.87. Epub 2014 Apr 10.

7.

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.

Taylor SB, Lewis CR, Olive MF.

Subst Abuse Rehabil. 2013 Feb 8;4:29-43. doi: 10.2147/SAR.S39684. eCollection 2013. Review.

8.

Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.

Trifilieff P, Martinez D.

Neuropharmacology. 2014 Jan;76 Pt B:498-509. doi: 10.1016/j.neuropharm.2013.06.031. Epub 2013 Jul 10. Review.

9.

Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence.

Trifilieff P, Martinez D.

Front Psychiatry. 2013 Jun 3;4:44. doi: 10.3389/fpsyt.2013.00044. eCollection 2013.

10.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

11.

Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.

Narendran R, Martinez D, Mason NS, Lopresti BJ, Himes ML, Chen CM, May MA, Price JC, Mathis CA, Frankle WG.

Synapse. 2011 Dec;65(12):1344-9. doi: 10.1002/syn.20970.

12.

Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence.

Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET.

Brain. 2011 Jul;134(Pt 7):2013-24. doi: 10.1093/brain/awr138. Epub 2011 Jun 20.

13.

Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC, Kumar D, Van Heertum R, Kleber HD, Nunes E.

Am J Psychiatry. 2011 Jun;168(6):634-41. doi: 10.1176/appi.ajp.2010.10050748. Epub 2011 Mar 15. Erratum in: Am J Psychiatry. 2011 May;168(5):553.

14.

Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.

Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van Heertum R, Kleber HD.

Am J Psychiatry. 2009 Oct;166(10):1170-7. doi: 10.1176/appi.ajp.2009.08121801. Epub 2009 Sep 1. Erratum in: Am J Psychiatry. 2009 Nov;166(11):1299.

15.

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Lohoff FW, Bloch PJ, Ferraro TN, Berrettini WH, Pettinati HM, Dackis CA, O'Brien CP, Kampman KM, Oslin DW.

Neurosci Lett. 2009 Apr 10;453(3):199-203. doi: 10.1016/j.neulet.2009.02.026. Epub 2009 Feb 21.

16.

Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Egaña LA, Cuevas RA, Baust TB, Parra LA, Leak RK, Hochendoner S, Peña K, Quiroz M, Hong WC, Dorostkar MM, Janz R, Sitte HH, Torres GE.

J Neurosci. 2009 Apr 8;29(14):4592-604. doi: 10.1523/JNEUROSCI.4559-08.2009.

17.

Imaging dopamine's role in drug abuse and addiction.

Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F.

Neuropharmacology. 2009;56 Suppl 1:3-8. doi: 10.1016/j.neuropharm.2008.05.022. Epub 2008 Jun 3. Review.

Supplemental Content

Support Center